Brundavan Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 16-06-2024
- Paid Up Capital ₹ 1.40 Cr
as on 16-06-2024
- Company Age 22 Year, 1 Day
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 30.65 Cr
as on 16-06-2024
- Satisfied Charges ₹ 3.86 Cr
as on 16-06-2024
- Revenue 13.06%
(FY 2023)
- Profit -35.49%
(FY 2023)
- Ebitda -32.38%
(FY 2023)
- Net Worth 10.94%
(FY 2023)
- Total Assets 52.09%
(FY 2023)
About Brundavan Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.40 Cr.
The company currently has active open charges totaling ₹30.65 Cr. The company has closed loans amounting to ₹3.86 Cr, as per Ministry of Corporate Affairs (MCA) records.
Venkat Gedipudi, Kanaka Gedipudi, Ramaiah Gedipudi, and One other member serve as directors at the Company.
- CIN/LLPIN
U24231TG2002PTC040136
- Company No.
040136
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Dec 2002
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Brundavan Laboratories Private Limited offer?
Brundavan Laboratories Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, API Intermediate, Anti Infective API, API (Active Pharmaceutical Ingredients), Terbutaline Sulphate API, Carvedilol Intermediates, 4-Hydroxy Carbazole, Nervous System and Antipsychotic API.
Who are the key members and board of directors at Brundavan Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramaiah Gedipudi  | Managing Director | 19-Dec-2002 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Venkat Gedipudi | Director | 01-Oct-2019 | Current |
| Kanaka Gedipudi | Director | 19-Dec-2002 | Current |
| Vallabhaneni Krishna | Director | 19-Dec-2002 | Current |
Financial Performance and Corporate Structure Insights of Brundavan Laboratories.
Brundavan Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.06% increase. The company also saw a substantial fall in profitability, with a 35.49% decrease in profit. The company's net worth Soared by an impressive increase of 10.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Brundavan Laboratories?
In 2023, Brundavan Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 24 Dec 2015 | ₹30.65 Cr | Open |
Syndicate Bank Creation Date: 24 Aug 2006 | ₹2.22 Cr | Satisfied |
Syndicate Bank Creation Date: 03 Feb 2005 | ₹1.64 Cr | Satisfied |
How Many Employees Work at Brundavan Laboratories?
Brundavan Laboratories has a workforce of 68 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Brundavan Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Brundavan Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
